Immunome Inc (IMNM)

May 05, 2026

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe

May 05, 2026

May 02, 2026

Why (IMNM) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 02, 2026

May 02, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Immunome (IMNM) and Resmed (RMD) - The Globe and Mail

May 02, 2026

May 01, 2026

Lake Street Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $30 - Moomoo

May 01, 2026

Apr 30, 2026

Universal Beteiligungs und Servicegesellschaft mbH Acquires New Position in Immunome, Inc. $IMNM - MarketBeat

Apr 30, 2026

Apr 29, 2026

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors - BioSpace

Apr 29, 2026

Apr 29, 2026

Immunome (IMNM) Submits NDA for Varegacestat to Treat Desmoid Tu - GuruFocus

Apr 29, 2026

Apr 29, 2026

Craig-Hallum Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $36 - Moomoo

Apr 29, 2026

Apr 29, 2026

Immunome submits drug application for desmoid tumor treatment - Investing.com

Apr 29, 2026

Apr 29, 2026

Immunome submits drug application for desmoid tumor treatment By Investing.com - Investing.com South Africa

Apr 29, 2026

Apr 29, 2026

Immunome (IMNM) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Apr 29, 2026

Apr 28, 2026

Why is IMNM stock rising today? - MSN

Apr 28, 2026

Apr 27, 2026

Immunome prices $400M stock offering at $21.50 a share - MSN

Apr 27, 2026

Apr 25, 2026

The Bull Case For Immunome (IMNM) Could Change Following Varegacestat’s ASCO 2026 Spotlight And NDA Timeline – Learn Why - simplywall.st

Apr 25, 2026

Apr 25, 2026

A Look At Immunome (IMNM) Valuation As Varegacestat Nears ASCO 2026 Spotlight And FDA NDA Filing - Yahoo Finance

Apr 25, 2026

Apr 24, 2026

[ARS] Immunome Inc. SEC Filing - Stock Titan

Apr 24, 2026

Apr 24, 2026

Immunome (IMNM) 2026 proxy: trial success, executive pay and key stockholder votes - Stock Titan

Apr 24, 2026

Apr 24, 2026

Immunome Desmoid Tumor Data And NDA Plan Test Growth Expectations - simplywall.st

Apr 24, 2026

Apr 23, 2026

Immunome (IMNM) Long-Term View | Immunome Inc. 23.8% EPS Miss, No Revenue EstimateMiss Estimates - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 22, 2026

Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting - BioSpace

Apr 22, 2026

Apr 21, 2026

Immunome’s desmoid tumor trial data selected for ASCO presentation By Investing.com - Investing.com Australia

Apr 21, 2026

Apr 21, 2026

Understanding Momentum Shifts in (IMNM) - Stock Traders Daily

Apr 21, 2026

Apr 21, 2026

Immunome’s desmoid tumor trial data selected for ASCO presentation - Investing.com

Apr 21, 2026

Apr 20, 2026

Immunome (IMNM) Stock: Buy, Sell, Hold? (Market Focus) 2026-04-20Pre Earnings - Cổng thông tin điện tử Tỉnh Sơn La

Apr 20, 2026

Apr 18, 2026

Is institutional money buying Immunome (IMNM) stock (+5.89%) 2026-04-18Certified Trade Ideas - UBND thành phố Hải Phòng

Apr 18, 2026

Apr 18, 2026

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Immunome (IMNM) and Eli Lilly & Co (LLY) - The Globe and Mail

Apr 18, 2026

Apr 17, 2026

Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33 - 富途牛牛

Apr 17, 2026

Apr 17, 2026

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 52.79% Potential Upside with Strong Buy Consensus - DirectorsTalk Interviews

Apr 17, 2026

Apr 17, 2026

IMNM News | IMMUNOME INC (NASDAQ:IMNM) - ChartMill

Apr 17, 2026

Apr 15, 2026

JPMorgan Chase & Co. Cuts Stock Holdings in Immunome, Inc. $IMNM - MarketBeat

Apr 15, 2026

Apr 15, 2026

Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 15, 2026

Apr 14, 2026

Immunome (IMNM) Price Forecast: Breakout Points to Higher Highs Ahead - FXEmpire

Apr 14, 2026

Apr 13, 2026

Death Cross: Can Immunome Inc be the next market leader2026 Technicals & Fast Exit/Entry Strategy Plans - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Stock Analysis: Is Immunome Inc part of any ETF2026 Retail Activity & Daily Volume Surge Signals - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Avoiding Lag: Real-Time Signals in (IMNM) Movement - Stock Traders Daily

Apr 10, 2026

Apr 08, 2026

Death Cross: Is Immunome Inc gaining market share2026 Key Lessons & Technical Pattern Based Buy Signals - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

LifeSci Capital Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40 - Moomoo

Apr 07, 2026

Apr 06, 2026

Is Immunome (IMNM) Stock Expanding | Price at $22.19, Up 1.60%Bullish Pattern - Xã Thanh Hà

Apr 06, 2026

Apr 05, 2026

Immunome CSO Sells Shares: Transaction Details & Company SnapshotNews and Statistics - IndexBox

Apr 05, 2026

Apr 05, 2026

Immunome (IMNM) Is Up 11.4% After CEO Share Buy And Positive Phase III DataWhat's Changed - Sahm

Apr 05, 2026

Apr 05, 2026

Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - AOL.com

Apr 05, 2026

Apr 05, 2026

Insider Sell: What is the long term forecast for Immunome Inc stockDividend Hike & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - The Motley Fool

Apr 04, 2026

Apr 04, 2026

A Look At Immunome (IMNM) Valuation After Oncology Progress EPS Upgrades And CEO Insider Buying - Sahm

Apr 04, 2026

Apr 04, 2026

Immunome, Inc. (IMNM) stock price, news, quote and history - Yahoo Finance Singapore

Apr 04, 2026

Apr 03, 2026

Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock By Investing.com - Investing.com South Africa

Apr 03, 2026

Apr 03, 2026

Immunome CFO Rosett sells $1.4m in shares By Investing.com - Investing.com Canada

Apr 03, 2026

Apr 03, 2026

Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock - Investing.com

Apr 03, 2026